ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)

Aug 13, 2013 · 8m 39s
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)
Description
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
Information
Author cancerGRACE
Organization cancerGRACE
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search